Clinical trial

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in…

NCT00003661 · Roswell Park Cancer Institute, Other · Completed

Key facts

NCT number NCT00003661
Title Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
Official title A Pilot Study of Unrelated Umbilical Cord Blood Transplantation in Children and Adults With Hematologic Malignancies
Lead sponsor Roswell Park Cancer Institute, Other
Status Completed
Phase Phase 2
Study type Interventional
Conditions Graft Versus Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neuroblastoma
Intervention type Biological, Drug, Procedure, Radiation
Interventions anti-thymocyte globulin, busulfan, cyclosporine, melphalan, methylprednisolone, umbilical cord blood transplantation, radiation therapy
Enrollment 3
Start date Jun 1, 1998
Primary completion Nov 1, 1999
Completion Mar 1, 2006
First posted Aug 4, 2004
Last update posted Mar 7, 2011
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies